SCHEMBL4616680

SCHEMBL4616680

COCCOCCOCCOc1ccc(CCO)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
MEN1 O00255 1/20 0.59
USP2 O75604 1/20 0.59
ALDH1A1 P00352 1/20 0.59
CYP3A4 P08684 1/20 0.59
MAPK1 P28482 1/20 0.59
CASP1 P29466 1/20 0.59
KMT2A Q03164 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
SLCO1B3 Q9NPD5 1/20 0.59
SLCO1B1 Q9Y6L6 1/20 0.59
APP P05067 9/20 0.50
HRH3 Q9Y5N1 2/20 0.48
KDM4E B2RXH2 1/20 0.47
RECQL P46063 1/20 0.47
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
PPARA Q07869 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3335173 0.90 LMNA (0.48) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL23266068 0.89 MEN1 (0.67) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL16559902 0.86 KDM4E (0.50) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL3096757 0.86 KDM4E (0.50) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL12703442 0.85 APP (0.57) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL6658231 0.85 HRH3 (0.59) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL6133622 0.84 HRH3 (0.53) LMNAMEN1USP2ALDH1A1CYP3A4
SCHEMBL3611926 0.83 KDM4E (0.61) MAPK1APPKDM4ERECQLL3MBTL1
SCHEMBL12703538 0.83 KDM4E (0.61) MAPK1APPKDM4ERECQLL3MBTL1
SCHEMBL23291231 0.83 TAAR1 (0.56) LMNAMEN1USP2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221702-A1 COMPOUNDS IMPERIAL INNOVATIONS LIMITED (GB) 2009-09-03 US disclosed
US-20090221702-A1 COMPOUNDS IMPERIAL INNOVATIONS LIMITED (GB) 2009-09-03 US disclosed
EP-1879562-A2 PHENOL DERIVATIVES AND THEIR USE TO MODULATE PKB ACTIVITY Imperial Innovations Limited (GB) 2008-01-23 EP disclosed
WO-2006097744-A2 PHENOL DERIVATIVES AND THEIR USE TO MODULATE PKB ACTIVITY IMPERIAL INNOVATIONS LIMITED (GB) 2006-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221702-A1 COMPOUNDS NCEH1, NME2, HRH3 LMNA 4129/4885MEN1 550/4885USP2 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.